the ongoing rise of New Psychoactive Substances (NPS), i.e. psychotropic molecules devised and synthesized to replicate the effects of traditional drugs of abuse in order to circumvent banned substances schedules, has been posing a challenge of enormous magnitude to substance detection systems and law enforcement worldwide. Still, it would be remiss to ignore the role played by the unprecedented public health emergency relating to the COVID-19 pandemic in the exacerbation of the NPS crisis.
New psychoactive substances and receding COVID-19 pandemic: really going back to normal? / Napoletano, Simona; Basile, Giuseppe; Lo Faro, Alfredo Fabrizio; Negro, Francesca. - In: ACTA BIOMEDICA. - ISSN 2531-6745. - 93:2(2022), pp. 1-5. [10.23750/abm.v93i2.13008]
New psychoactive substances and receding COVID-19 pandemic: really going back to normal?
Napoletano, Simona
;Basile, Giuseppe;Negro, Francesca
2022
Abstract
the ongoing rise of New Psychoactive Substances (NPS), i.e. psychotropic molecules devised and synthesized to replicate the effects of traditional drugs of abuse in order to circumvent banned substances schedules, has been posing a challenge of enormous magnitude to substance detection systems and law enforcement worldwide. Still, it would be remiss to ignore the role played by the unprecedented public health emergency relating to the COVID-19 pandemic in the exacerbation of the NPS crisis.| File | Dimensione | Formato | |
|---|---|---|---|
|
Napoletano_New-psycoactive_2022.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
83.24 kB
Formato
Adobe PDF
|
83.24 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
